Articles

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

Centre for Clinical Transfusion Research, Sanquin Research, Leiden, the Netherlands;Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, USA
Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands
Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, USA
Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands
Service d’Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris and Université Paris 7, Paris, France
Department of Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece
Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, Praha, Czech Republic
Department of Medicine, Division of Hematology, Karolinska Institutet, Stockholm, Sweden
Department of Haematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
Department of Internal Medicine V (Haematology and Oncology), Innsbruck Medical University, Innsbruck, Austria
Department of Haematology, Aarhus University Hospital, Aarhus, Denmark
Department of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center and Sackler Medical Faculty, Tel Aviv University, Tel Aviv, Israel
Department of Haematology, Oncology and Internal Medicine, Warszawa Medical University, Warszawa, Poland
Department of Hematology Oncology, Fondazione Istituto Di Ricovero e Cura a Carettere Scientifico, Policlinico San Matteo, University of Pavia, Pavia, Italy
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Department of Hematology, Hospital da Luz, Lisbon, Portugal
Department of Haematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Düsseldorf, Germany
Clinic of Hematology - Clinical Center of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Department of Internal Medicine, Division of Hematology, Merkur University Hospital, Zagreb, Croatia
Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, UK
Service d’Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris and Université Paris 7, Paris, France
Service d’Hématologie, Centre Hospitalier Universitaire Brabois Vandoeuvre, Nancy, France
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands
Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands
Department of Hematology – Cancer Center Amsterdam VU University Medical Center, Amsterdam, the Netherlands
Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands
Unit Transfusion Medicine, Sanquin Blood Bank, Amsterdam, the Netherlands
St. James’s Institute of Oncology, Leeds Teaching Hospitals, Leeds, UK
Department of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, USA
Vol. 105 No. 3 (2020): March, 2020 https://doi.org/10.3324/haematol.2018.212332